Home

Download

Statistics

Examples

Help

Contact

	Fusion Gene Summary
	Fusion Gene ORF analysis
	Fusion Genomic Features
	Fusion Protein Features
	Fusion Gene Sequence
	Fusion Gene PPI analysis
	Related Drugs
	Related Diseases

Fusion gene:C3orf58-SLC9A9 (FusionGDB2 ID:11728)

Fusion Gene Summary for C3orf58-SLC9A9

Fusion gene summary

Fusion gene information	Fusion gene name: C3orf58-SLC9A9
	Fusion gene ID: 11728
		Hgene	Tgene
	Gene symbol	C3orf58	SLC9A9
	Gene ID	205428	285195
	Gene name	divergent protein kinase domain 2A	solute carrier family 9 member A9
	Synonyms	C3orf58\|DIA1\|GoPro49\|HASF	AUTS16\|NHE9
	Cytomap	3q24	3q24
	Type of gene	protein-coding	protein-coding
	Description	divergent protein kinase domain 2AGolgi Protein of 49 kDaGolgi protein GoPro49UPF0672 protein C3orf58deleted in autism 1deleted in autism protein 1hypoxia and AKT-induced stem cell factorhypoxia and Akt induced stem cell factor	sodium/hydrogen exchanger 9Na(+)/H(+) exchanger 9putative protein product of Nbla00118sodium/proton exchanger NHE9solute carrier family 9 (sodium/hydrogen exchanger)solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
	Modification date	20200313	20200313
	UniProtAcc	.	.
	Ensembl transtripts involved in fusion gene	ENST00000493396, ENST00000315691, ENST00000441925, ENST00000495414,	ENST00000316549, ENST00000498717,
Fusion gene scores	* DoF score	1 X 1 X 1=1	8 X 7 X 6=336
	# samples	1	9
	** MAII score	log2(1/1*10)=3.32192809488736	log2(9/336*10)=-1.90046432644909 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0
Context	PubMed: C3orf58 [Title/Abstract] AND SLC9A9 [Title/Abstract] AND fusion [Title/Abstract]
Most frequent breakpoint	C3orf58(143691831)-SLC9A9(143515745), # samples:1
Anticipated loss of major functional domain due to fusion event.

* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Partner	Gene	GO ID	GO term	PubMed ID
Hgene	C3orf58	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	23784961
Hgene	C3orf58	GO:0060038	cardiac muscle cell proliferation	23784961

Fusion gene breakpoints across C3orf58 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene breakpoints across SLC9A9 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

Source	Disease	Sample	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
ChimerDB4	COAD	TCGA-A6-2674-01A	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-

Top

Fusion Gene ORF analysis for C3orf58-SLC9A9

Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.

ORF	Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand
3UTR-3CDS	ENST00000493396	ENST00000316549	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
3UTR-intron	ENST00000493396	ENST00000498717	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
5CDS-intron	ENST00000315691	ENST00000498717	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
In-frame	ENST00000315691	ENST00000316549	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
intron-3CDS	ENST00000441925	ENST00000316549	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
intron-3CDS	ENST00000495414	ENST00000316549	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
intron-intron	ENST00000441925	ENST00000498717	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-
intron-intron	ENST00000495414	ENST00000498717	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-

ORFfinder result based on the fusion transcript sequence of in-frame fusion genes.

Henst

Tenst

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

Seq length
(transcript)

BP loci
(transcript)

Predicted start
(transcript)

Predicted stop
(transcript)

Seq length
(amino acids)

ENST00000315691

C3orf58

chr3

143691831

ENST00000316549

SLC9A9

chr3

143515745

4232

1192

535

2751

738

DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.

Henst	Tenst	Hgene	Hchr	Hbp	Hstrand	Tgene	Tchr	Tbp	Tstrand	No-coding score	Coding score
ENST00000315691	ENST00000316549	C3orf58	chr3	143691831	+	SLC9A9	chr3	143515745	-	0.005578724	0.9944213

Top

Fusion Genomic Features for C3orf58-SLC9A9

FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.

Hgene

Hchr

Hbp

Hstrand

Tgene

Tchr

Tbp

Tstrand

1-p

p (fusion gene breakpoint)

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for C3orf58-SLC9A9

Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:143691831/chr3:143515745)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.

Main function of each fusion partner protein. (from UniProt)

Hgene	Tgene
.	.
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.	FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at
download page

* Minus value of BPloci means that the break pointn is located before the CDS.

- In-frame and retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

127_147

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

165_185

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

204_224

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

236_256

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

278_298

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

302_322

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

323_343

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

365_385

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

387_407

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

430_450

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

466_486

126

646.0

Transmembrane

Helical

- In-frame and not-retained protein feature among the 13 regional features.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Protein feature

Protein feature note

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

21_41

126

646.0

Transmembrane

Helical

Tgene

SLC9A9

chr3:143691831

chr3:143515745

ENST00000316549

46_66

126

646.0

Transmembrane

Helical

Top

Fusion Gene Sequence for C3orf58-SLC9A9

For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

>11728_11728_1_C3orf58-SLC9A9_C3orf58_chr3_143691831_ENST00000315691_SLC9A9_chr3_143515745_ENST00000316549_length(transcript)=4232nt_BP=1192nt
CTTGGTCTCAGGAGAGCCAGCGCGCACAAGCAAGGGTGTGCGGCTCTGAGACGTGCGTTGCTGCTTGTGGGTGTGAGACATCCTAGCTCC
TCTTCCCCTTCCGTGAGTCCCTCCTTTCCTCGCAGACCCCACTTGTCGTGGCTGGCTGCCGCCGCAGCTCTTGTGCGAAGCCAGCAGTGC
GCGTGCGCGCGGGCACGGGCGCGCGACCGTCGGGTCCCCGCGCTCCCTCCCCCTCCCGCTCCTCTATAACTTGGCTGGCGTGGAGGAGGC
GCCGCCGGAGTCGGAGGGCGGGGAGCTAGGAGGAGGGAGCTCGAGAGTTGTGGAGACTAGTGACTGGGAGAAGTCGCAGCCCGCTCAGGC
CCGCGCCTTCCCGCTCCCCGTCTTCCTCTCTCACACACCTACTCCGCCCTCCGCCCCAGCCCGCGCGCTAGCTCCTTCTCTCGCCCGGGG
TTCCTGCCGGTAGCTCTCCGGGTCTTGGCGCGGCGGGGGCGCCCCGGGGGTGCCCTCGCCCTCCCGTTGCGGGCGGGCGGGCGGTATGTG
GCGCCTGGTGCCCCCGAAGCTGGGCCGCCTGTCCCGCTCGCTGAAGCTGGCGGCGCTGGGCAGCCTGTTGGTGCTGATGGTGCTGCACTC
GCCGTCGCTGCTCGCCTCTTGGCAGCGCAACGAACTGACCGACCGGCGCTTCCTGCAGCTCAATAAGTGCCCGGCGTGCTTCGGCACGAG
CTGGTGCCGCCGCTTCCTCAACGGGCAGGTGGTATTCGAGGCGTGGGGCCGCTTGCGCCTGCTGGACTTCCTCAACGTGAAGAACGTGTA
CTTCGCGCAGTACGGCGAGCCCCGCGAGGGCGGCCGCCGCCGAGTGGTGCTCAAGCGCCTCGGCTCGCAGCGCGAGCTGGCGCAGCTCGA
CCAGAGCATCTGCAAGCGGGCCACCGGCCGGCCCCGCTGCGACCTGCTGCAGGCCATGCCCCGGACCGAGTTCGCGCGCCTCAACGGCGA
CGTGCGTCTGCTCACGCCCGAGGCGGTGGAGGGCTGGTCGGACCTGGTGCACTGCCCCTCGCAGCGCCTTCTCGACCGCCTGGTGCGCCG
CTACGCGGAGACCAAGGACTCGGGCAGCTTCCTGCTTCGCAACCTCAAGGACTCGGAGCGCATGCAGCTGCTGCTGACCCTGGCCTTCAA
CCCCGAGCCGCTGGTGCTACAGATGACATTTGATCCAGAAATCTTCTTCAATGTTTTACTGCCACCAATTATATTTCATGCAGGATATAG
TCTAAAGAAGAGACACTTTTTTCAAAACTTAGGATCTATTTTAACGTATGCCTTCTTGGGAACTGCCATCTCCTGCATCGTCATAGGGTT
AATTATGTATGGTTTTGTGAAGGCTATGATACATGCTGGCCAGCTGAAAAATGGAGACTTTCATTTCACTGACTGTTTATTTTTTGGTTC
ACTGATGTCTGCTACAGATCCAGTGACAGTGCTGGCCATTTTCCATGAACTGCACGTCGACCCTGACCTGTACACACTCTTGTTTGGAGA
GAGTGTGTTGAATGATGCAGTGGCCATAGTCCTTACATATTCTATATCCATTTACAGTCCCAAGGAGAATCCAAATGCATTTGATGCCGC
AGCATTCTTCCAGTCTGTGGGGAATTTCCTGGGAATCTTCGCTGGCTCATTTGCAATGGGGTCTGCGTATGCCATCATCACAGCACTGTT
GACCAAATTTACCAAGCTGTGTGAGTTCCCGATGCTGGAAACCGGCCTGTTTTTCCTGCTTTCTTGGAGTGCCTTCCTGTCTGCCGAGGC
TGCCGGCCTAACAGGGATAGTTGCTGTTCTCTTCTGTGGAGTCACACAAGCACATTATACCTACAACAATCTGTCTTCGGATTCCAAAAT
AAGAACTAAACAGTTGTTTGAATTTATGAACTTTTTGGCGGAGAACGTCATCTTCTGTTACATGGGCCTGGCACTGTTCACGTTCCAGAA
TCATATCTTTAATGCTCTTTTTATACTTGGAGCCTTTCTAGCAATTTTTGTTGCCAGAGCCTGCAACATATATCCCCTCTCCTTCCTCCT
GAATCTAGGCCGAAAACAGAAGATCCCCTGGAACTTTCAGCACATGATGATGTTTTCAGGTTTGCGAGGAGCGATCGCATTTGCCTTAGC
TATTCGGAACACAGAATCTCAGCCCAAACAAATGATGTTTACCACTACGCTGCTCCTCGTGTTCTTCACTGTCTGGGTATTTGGAGGAGG
AACAACCCCCATGTTGACTTGGCTTCAGATCAGAGTTGGCGTGGACCTGGATGAAAATCTGAAGGAGGACCCCTCCTCACAACACCAGGA
AGCAAATAACTTGGATAAAAACATGACGAAAGCAGAGAGTGCTCGGCTCTTCAGAATGTGGTATAGCTTTGACCACAAGTATCTGAAACC
AATTTTAACCCACTCTGGTCCTCCGCTGACTACAACATTACCTGAATGGTGTGGTCCGATTTCCAGGCTGCTTACCAGTCCTCAAGCCTA
TGGGGAACAGCTAAAAGAGGATGATGTGGAATGCATTGTAAACCAGGATGAACTAGCCATAAATTACCAGGAGCAAGCCTCCTCACCCTG
CAGTCCTCCTGCAAGGCTAGGTCTGGACCAGAAAGCTTCACCCCAGACGCCAGGCAAGGAAAACATTTATGAGGGAGACCTCGGCCTGGG
AGGCTATGAACTCAAGCTTGAGCAAACTTTGGGTCAATCCCAGTTGAATTAATTGGCATGAAGAGTACAGATGTAATCACAAGTAATGCA
AGACTCACTGAGGAATACAAGCCAAGCTGATGAGGCAGTACAGGGGAGAGGCTGGAAAACATATTAAGAGCATAAATTGGAGAGAATCAA
AGCCTTGTCACATGGATCCTCTGGTGCCTGAAGAAATGAGATTTTATTATCCCTCTCTATTATGCAAATGAATTTAGTTTTTTGACAGCA
GCCATTCTGATTACTGGATTGGCTGGGGTGGGGATGGAGGTATCAGGAGTCTAGCTGCTGGAGGATGGGACAGCTGTGCTGGGTCTTCAG
GGCATTTCTGCTGCGAATGCGGCTCTCCAGGCCCTTCACTTCTATTCTGGATTTTATTCCCTCCATTAAGGAGAGTTTAAAAATAAAAGA
AAGCTTCTGAGAGTAAACATTTTGCTCCTAAGCTGAAGGGAATGCCCAGCTATTTAGTAAGTGATAAGTTTCTTATTTTGAGGACTTGAC
TCCCATTTGCTCTCAGTGACCCCAGGGCAGAGCCCAGAGAAGTGTTCCGTACCCACTGCTGATGGTTTCCCAGAGCCCACACTGAGTTGA
AGAACCTATTGTTCTTCTTGGCATCCTTCTTATGCTACTTCTCCCATCGCTCAAAGGGGTTGCCTATGGCTGGGTGTGCCCTGCCCTAAA
TGCAGCACCACTTTCAAGCTTAGTAGGACCATTCCAAGAAAACCAGGTTTCTTCTCCCCATACCACGTTGTGCCTGAAGAACAAGCCTTC
CCGTCCTTGCCTGCATGTGAGTCACTTCTTGGCTGTGCAGCAGGTCCCCCCCTCCCCGCGATATGCTGGAGGGTAGGATTCTGCAGCCTG
TGTTGCTCTCTACCTGGCAGCAGACTGTGCAGGAGCCCCAACCTGTCCTCCAATTCCAGCATTCACAGCTGATGAGCAGTGCAGGAGCAG
GGCGAGAGGAACAGAGCCAATGATGTGTGGGTTACACTGAGGAGCCAAGGACAGGGCCTCAGGTCTCCCCCTTACAAGGCGTGGCTCATG
GCCTGCATTCCAGAGACCAACATGATAGCTTTTAATTCAGCTGCATGACCTGTGCCTTTTAAGCCATAAAGATACCTCAAGCCTAGCACC
TCTTGAAATCCAGATGTTCATATTAGACTCGAAAAAATAGGCTCCAGGCCTAGGTGCCCAGGCTATGATGAGTCTGCTTTTGAAGGAGGT
AGGGAATGACATCTTCCTTGGACCCAAAGCTTAAAAGTAATGTATGCTTTGCTGACCACTGTTTGTTAGGCCTTAAACAACATTCACTGT
GGTGGTATCAGGCACACTGCTATGTGCATCAATTATTTTTTTGCTTTCCAAACAGAATCTCTGGGGCACAAGTTTTACACTCAAGCTAAG
TATAACTTTGTCATTTCAGGTAAATATGACAAGTGGTGGAGCATGAAGTTTTCTAATTTGACTTAATCCTAATAAATTTTTGTTACAAAG

>11728_11728_1_C3orf58-SLC9A9_C3orf58_chr3_143691831_ENST00000315691_SLC9A9_chr3_143515745_ENST00000316549_length(amino acids)=738AA_BP=185
MWRLVPPKLGRLSRSLKLAALGSLLVLMVLHSPSLLASWQRNELTDRRFLQLNKCPACFGTSWCRRFLNGQVVFEAWGRLRLLDFLNVKN
VYFAQYGEPREGGRRRVVLKRLGSQRELAQLDQSICKRATGRPRCDLLQAMPRTEFARLNGDVRLLTPEAVEGWSDLVHCPSQRLLDRLV
RRYAETKDSGSFLLRNLKDSERMQLLLTLAFNPEPLVLQMTFDPEIFFNVLLPPIIFHAGYSLKKRHFFQNLGSILTYAFLGTAISCIVI
GLIMYGFVKAMIHAGQLKNGDFHFTDCLFFGSLMSATDPVTVLAIFHELHVDPDLYTLLFGESVLNDAVAIVLTYSISIYSPKENPNAFD
AAAFFQSVGNFLGIFAGSFAMGSAYAIITALLTKFTKLCEFPMLETGLFFLLSWSAFLSAEAAGLTGIVAVLFCGVTQAHYTYNNLSSDS
KIRTKQLFEFMNFLAENVIFCYMGLALFTFQNHIFNALFILGAFLAIFVARACNIYPLSFLLNLGRKQKIPWNFQHMMMFSGLRGAIAFA
LAIRNTESQPKQMMFTTTLLLVFFTVWVFGGGTTPMLTWLQIRVGVDLDENLKEDPSSQHQEANNLDKNMTKAESARLFRMWYSFDHKYL
KPILTHSGPPLTTTLPEWCGPISRLLTSPQAYGEQLKEDDVECIVNQDELAINYQEQASSPCSPPARLGLDQKASPQTPGKENIYEGDLG

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for C3orf58-SLC9A9

Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in
ChiPPI page.

Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)

Hgene

Hgene's interactors

Tgene

Tgene's interactors

- Retained PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Still interaction with

- Lost PPIs in in-frame fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

- Retained PPIs, but lost function due to frame-shift fusion.

Partner

Gene

Hbp

Tbp

ENST

Strand

BPexon

TotalExon

Protein feature loci

*BPloci

TotalLen

Interaction lost with

Top

Related Drugs for C3orf58-SLC9A9

Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)

Partner

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

Related Diseases for C3orf58-SLC9A9

Diseases associated with fusion partners.
(DisGeNet 4.0)

Partner

Gene

Disease ID

Disease name

# pubmeds

Source